Modifying lactose permease amino acids increases 2'-fucosyllactose yield by enhancing substrate uptake efficiency.
Recombinant microorganisms convert sucrose into high-molecular-weight polylactate, eliminating organic solvents and chain coupling agents.
Engineered polymerase variants enhance thermostability and sequencing efficiency through directed evolution.
Chemoenzymatic sulfation of heparosan intermediates produces biosynthetic heparin that meets USP bioequivalence standards for porcine heparin.
CPT, NgBR, and REF proteins bind to rubber particles to boost synthesis activity without damaging trees via chemical inducers.
Electrophilic warheads form covalent bonds with cysteine 817 to resolve the trade-off between therapeutic efficacy and off-target kinase inhibition.
Heterologous CYP71A8 and CYP71D10 expression in recombinant yeast enables de novo synthesis of the key andrographolide intermediate.
Engineered tRNASec allows selenocysteine incorporation without a SECIS element, resolving manufacturing complexity and improving production efficiency.
Engineered LovD variants catalyze direct simvastatin synthesis via acyl thioester transfer, eliminating lovastatin purification steps.
Biomimetic condensates concentrate enzymes and substrates via liquid-liquid phase separation to enhance catalytic efficiency.